Mölnlycke opens new manufacturing plant in Havirov, Czech Republic

Mölnlycke opens new manufacturing plant in Havirov, Czech Republic – enhancing efficiency in the operating room

May 18 2017

The opening of the new plant marks the start of Mölnlycke’s largest investment to date, EUR 67 million (£57.5 million), and is one of the largest foreign direct investment in the country in recent years. The new plant is a milestone for the Procedure tray business, and increases the company’s capacity to drive operating room efficiency.

Milton Keynes, UK – 18 May 2017

Mölnlycke, a world-leading medical products and solutions company, is pleased to announce  the opening of a new manufacturing plant in Havirov, Czech Republic. The investment is Mölnlycke’s largest to date, EUR 67 million (£57.5 million), and will help create value for customers with cost-effective and safe surgical solutions. Mölnlycke’s truly customised surgical Procedure trays mean less preparation time and less opening and set-up time, leading to improved efficiency in the operating room. With everything collected in a Mölnlycke Procedure tray, staff can reduce preparation time by up to 40%.[1]

Emmanuel Chilaud, General Manager, Procedure tray factories, comments:

“We know from experience working with hospitals that one size does not fit all; every procedure is different and each hospital has its preferred configuration. We are now offering health care professionals a wider range of truly customised surgical solutions. There is no limit to the number of combinations of trays. We offer tailor made solutions, and can customise a procedure tray to match, in one pack. With Mölnlycke’s customised surgical procedure trays, the company can ensure high-quality care and patient safety through accuracy and consistency for every procedure set-up.”

The new plant will increase the logistic solution’s flexibility, as Mölnlycke will be assembling trays to order and will sterilise them in-house before shipping either directly or via distribution centres to customers, depending on customer profile and needs. The products manufactured at the factory will sell worldwide from day one, and are currently authorised for sale in 60 countries.

Richard Twomey, CEO of Mölnlycke, comments:

“We are excited about the opening of a new manufacturing plant in the Czech Republic. Mölnlycke is growing fast and this investment will secure our ability to meet the increasing demand from our customers. The new plant is also an important step on a larger journey for Mölnlycke to advance performance in healthcare within our three focus areas: Wound management, Prevention, and Surgical solutions.”

View Mölnlycke's detailed infographic here.

[1] References: 4. Greiling, M. A multinational case study to evaluate and quantify time-saving by using custom procedure trays for operating room efficiency. Data presented at European Association of Hospital Managers, September 2010 (poster).

For more information, please contact:

Liz Neal, Head of PR and Communications UK


07787 432560

Notes for the editors:

Mölnlycke is a world leading medical solutions company.  Our purpose is to advance performance in healthcare across the world. That is why we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. We develop and bring to market innovative wound care and surgical solutions along the entire continuum of care – from prevention to post-acute settings. Our solutions provide value for money, supported by clinical and health economic evidence.

Mölnlycke was founded in 1849. Nowadays our solutions are available in around 100 countries; we are the number one global provider of advanced wound care and single-use surgical products; and we are Europe's largest provider of customised trays.  Our headquarters are in Gothenburg, Sweden and we have about 7,500 employees around the world.